Price cuts on critical medicines on the way as the Health Minister convenes meeting with pharma lobbies
Price reductions on a number of essential medications could take place shortly since Health Minister Mansukh Mandaviya is anticipated to meet with leading producers and pharma organizations.
Kanpur traders' boycott of Macleods' anti-TB medications hinders the government's effort to eradicate TB
After local drug dealers in Kanpur, Uttar Pradesh, boycotted Macleods Pharmaceuticals’ products, including anti-TB medications, the government’s tuberculosis (TB) elimination programme was put on hold.
DoP rejects review petition from six firms and upholds NPPA's mechanism of retail price determination for drugs
National Pharmaceutical Pricing Authority of setting the retail price for anti-diabetic drug formulations that recently went off patent was upheld by the Department of Pharmaceuticals (DoP).
Pharma industry calls for future vaccine access thatis more equitable
The pharmaceutical sector said it was prepared to reserve dosages for distribution to lower-income nations when it made a system proposal to allow for more fair access to vaccines and medicines in the event of pandemics.
Gavi accepts malaria vaccine applications
In order to protect children from a disease that claims hundreds of thousands of lives each year in Africa, Gavi is launching its first application window for funding the distribution of the first-ever malaria vaccine.
European Medicines Agency approves Byondis' application for trastuzumab duocarmazine
European Medicines Agency has approved the Marketing Authorization Application (MAA) for the Byondis’s investigational anti-HER2 antibody-drug conjugate, which is intended for patients with HER2-positive, locally advanced or metastatic breast cancer that is unresectable.
Torrent Pharma anticipates entering the diagnostics market
Torrent Pharmaceuticals, located in Ahmedabad, is entering the diagnostics market in the next two to three months after its rival Lupin launched a related project last year.
